1. Home
  2. GXO vs KRYS Comparison

GXO vs KRYS Comparison

Compare GXO & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GXO Logistics Inc.

GXO

GXO Logistics Inc.

HOLD

Current Price

$53.74

Market Cap

5.4B

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$246.49

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GXO
KRYS
Founded
2021
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.3B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
GXO
KRYS
Price
$53.74
$246.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
9
Target Price
$62.00
$214.22
AVG Volume (30 Days)
1.0M
272.8K
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
275.72
EPS
0.76
6.66
Revenue
$12,921,000,000.00
$373,164,000.00
Revenue This Year
$13.31
$36.14
Revenue Next Year
$5.86
$41.80
P/E Ratio
$70.68
$37.07
Revenue Growth
16.94
54.51
52 Week Low
$30.46
$122.80
52 Week High
$57.99
$246.94

Technical Indicators

Market Signals
Indicator
GXO
KRYS
Relative Strength Index (RSI) 60.77 85.32
Support Level $51.90 $213.83
Resistance Level $53.56 $241.65
Average True Range (ATR) 1.26 7.92
MACD 0.55 2.15
Stochastic Oscillator 91.88 97.04

Price Performance

Historical Comparison
GXO
KRYS

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: